Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. It is given by injection into a vein. Common side effects include bone marrow suppression, hearing problems, incl… WebCisplatin is in a class of medications known as platinum-containing compounds. It works by stopping or slowing the growth of cancer cells. How should this medicine be used? …
CISplatin Injection - Food and Drug Administration
WebFeb 16, 2024 · Cisplatin can harm your kidneys, especially if you also use certain medicines for infections, cancer, osteoporosis, organ transplant rejection, bowel … WebMetode: Penelitian ini adalah studi eksperimental pada tikus yang diberikan cisplatin dan kurkumin 100 mg/kgbb (Cur100) atau cisplatin dan nanokurkumin 100 mg/kgbb (Nanocur100) atau cisplatin dan nanokurkumin 50mg/kgbb (Nanocur50). Masing-masing kelompok terdiri dari 4 ekor tikus. Kurkumin dan nanokurkumin diberikan selama 7 hari. forever berry nectar bienfaits
cisplatin - UpToDate
WebMar 2, 2024 · FK866 induces the effects of cisplatin in CCA cells. (A-C) CCA cells (HuCCT1, KMCH, and EGI) were treated with FK866 (0-1 nM), cisplatin (0-1 µM), or FK866 (0-1 nM) in combination with... WebSimpulan : Penambahan mannitol pada hidrasi memiliki risiko lebih besar terhadap kejadian AKI pasca kemoterapi Cisplatin dosis tinggi. Kata Kunci : Cisplatin dosis tinggi, mannitol, acute kidney injury Background : The addition of mannitol to saline hydration has been used frequently for preventing cisplatin induced acute kidney injury (AKI). WebLymphokine activated killer (LAK) cells generated in the presence of cisplatin/FK-565 along with interleukin-2 (IL-2) showed enhanced binding to tumor cells as compared with LAK cells generated in the presence of IL-2 alone. The LAK cells showed a reorientation of cellular organelles in the presence of tumor cells. forever 21 tysons closing